AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update

Sidney C. Smith; Emelia J. Benjamin; Robert O. Bonow; Lynne T. Braun; Mark A. Creager; Barry A. Franklin; Raymond J. Gibbons; Scott M. Grundy; Loren F. Hiratzka; Daniel W. Jones; Donald M. Lloyd-Jones; Margo Minissian; Lori Mosca; Eric D. Peterson; Ralph L. Sacco; John Spertus; James H. Stein; Kathryn A. Taubert

doi:10.1016/j.jacc.2011.10.824

AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update

Sidney C. Smith, Emelia J. Benjamin, Robert O. Bonow, Lynne T. Braun, Mark A. Creager, Barry A. Franklin, Raymond J. Gibbons, Scott M. Grundy, Loren F. Hiratzka, Daniel W. Jones, Donald M. Lloyd-Jones, Margo Minissian, Lori Mosca, Eric D. Peterson, Ralph L. Sacco, John Spertus, James H. Stein, Kathryn A. Taubert

Cardiovascular Medicine

Research output: Contribution to journal › Article › peer-review

541 Scopus citations

Original language	English (US)
Pages (from-to)	2432-2446
Number of pages	15
Journal	Journal of the American College of Cardiology
Volume	58
Issue number	23
DOIs	https://doi.org/10.1016/j.jacc.2011.10.824
State	Published - Nov 29 2011

Keywords

AHA Scientific Statements
coronary disease
risk factors
secondary prevention
vascular disease

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jacc.2011.10.824

Cite this

Smith, S. C., Benjamin, E. J., Bonow, R. O., Braun, L. T., Creager, M. A., Franklin, B. A., Gibbons, R. J., Grundy, S. M., Hiratzka, L. F., Jones, D. W., Lloyd-Jones, D. M., Minissian, M., Mosca, L., Peterson, E. D., Sacco, R. L., Spertus, J., Stein, J. H., & Taubert, K. A. (2011). AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update. Journal of the American College of Cardiology, 58(23), 2432-2446. https://doi.org/10.1016/j.jacc.2011.10.824

Smith, SC, Benjamin, EJ, Bonow, RO, Braun, LT, Creager, MA, Franklin, BA, Gibbons, RJ, Grundy, SM, Hiratzka, LF, Jones, DW, Lloyd-Jones, DM, Minissian, M, Mosca, L, Peterson, ED, Sacco, RL, Spertus, J, Stein, JH & Taubert, KA 2011, 'AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update', Journal of the American College of Cardiology, vol. 58, no. 23, pp. 2432-2446. https://doi.org/10.1016/j.jacc.2011.10.824

@article{44eccdf4a6b543e6899973a0962e800f,

title = "AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update",

keywords = "AHA Scientific Statements, coronary disease, risk factors, secondary prevention, vascular disease",

author = "Smith, {Sidney C.} and Benjamin, {Emelia J.} and Bonow, {Robert O.} and Braun, {Lynne T.} and Creager, {Mark A.} and Franklin, {Barry A.} and Gibbons, {Raymond J.} and Grundy, {Scott M.} and Hiratzka, {Loren F.} and Jones, {Daniel W.} and Lloyd-Jones, {Donald M.} and Margo Minissian and Lori Mosca and Peterson, {Eric D.} and Sacco, {Ralph L.} and John Spertus and Stein, {James H.} and Taubert, {Kathryn A.}",

note = "Funding Information: Reviewer Disclosures Reviewer Employment Research Grant Other Research Support Speaker's Bureau/ Honoraria Expert Witness Ownership Interest Consultant/Advisory Board Other Elliott M. Antman Brigham &amp;amp;amp;amp; Women's Hospital None None None None None None None Jeffrey L. Anderson Intermountain Medical Center None None None None None AstraZeneca * None Gary J. Balady Boston Medical Center None None None None None None None Eric R. Bates University of Michigan None None None None None AstraZeneca * ; Daiichi Sankyo * ; Eli Lilly * ; Merck * ; Sanofi Aventis * None Vera Bittner University of Alabama at Birmingham Clinical site PI for multicenter trials funded by: Roche/Genentech † ; Gilead; GSK † ; NIH/Abbott † ; NIH/Yale † None None None None Roche/Genentech * ; Amarin * ; Pfizer * None Ann F. Bolger University of California, San Francisco None None None None None None None Victor A. Ferrari University of Pennsylvania None None None None None Board of Trustees, Society for Cardiovascular Magnetic Resonance (no monetary value) * ; Editorial Board, Journal of Cardiovascular Magnetic Resonance (no monetary value) * None Stephan Fihn Department of Veterans Affairs and University of Washington None None None None None None None Gregg Fonarow UCLA NHLBI † ; AHRQ † None None None None Novartis † ; Medtronic * None Federico Gentile Centro Medico diagnostic, Naples-Italy None None None None None None None Larry B. Goldstein Duke University None None None None None None None Jonathan Halperin Mount Sinai Medical Center None None None None None Boehringer Ingelheim † ; Astellas Pharma, US * ; Bristol-Myers Squibb * ; Daiichi Sankyo * ; Johnson &amp;amp;amp;amp; Johnson * ; Pfizer, Inc * ; Sanofi-Aventis * None Courtney Jordan University of Minnesota None None None None None None None Noel Bairey Merz Cedars-Sinai Medical Center Gilead † NHLBI † Mayo Foundation * ; SCS Healthcare † ; Practice Point Communications * ; Inst for Professional Education * ; Medical Education Speakers Network * ; Minneapolis Heart Institute * ; Catholic Healthcare West * ; Novant Health * ; HealthScience Media Inc * ; Huntsworth Health * ; WomenHeart Coalition * ; Los Robles Medical Center * ; Monterrey Community Hospital (honorarium, donated to ACC) * ; Los Angeles OB-GYN Society * ; Pri-Med * ; North American Menopause Society * None Medtronic † UCSF * ; Society for Women's Health Research * ; Interquest * ; Dannemiller * ; Navvis &amp;amp;amp;amp; Co * ; Springer SBM LLC * ; Duke * ; NHLBI * ; Italian National Institutes of Health * ; Gilead * None L. Kristin Newby Duke University None None None None None None None Patrick O'Gara Brigham &amp;amp;amp;amp; Women's Hospital None None None None None Lantheus Medical Imaging * None Thomas W. Rooke Mayo Clinic None None None None None Merck–Adjudication (Event) Committee * None Vincent Sorrell University of Arizona None None Lantheus Medical Imaging † None None None None ",

year = "2011",

month = nov,

day = "29",

doi = "10.1016/j.jacc.2011.10.824",

language = "English (US)",

volume = "58",

pages = "2432--2446",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",

publisher = "Elsevier USA",

number = "23",

}

TY - JOUR

T1 - AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease

T2 - 2011 update

AU - Smith, Sidney C.

AU - Benjamin, Emelia J.

AU - Bonow, Robert O.

AU - Braun, Lynne T.

AU - Creager, Mark A.

AU - Franklin, Barry A.

AU - Gibbons, Raymond J.

AU - Grundy, Scott M.

AU - Hiratzka, Loren F.

AU - Jones, Daniel W.

AU - Lloyd-Jones, Donald M.

AU - Minissian, Margo

AU - Mosca, Lori

AU - Peterson, Eric D.

AU - Sacco, Ralph L.

AU - Spertus, John

AU - Stein, James H.

AU - Taubert, Kathryn A.

N1 - Funding Information: Reviewer Disclosures Reviewer Employment Research Grant Other Research Support Speaker's Bureau/ Honoraria Expert Witness Ownership Interest Consultant/Advisory Board Other Elliott M. Antman Brigham &amp;amp;amp;amp; Women's Hospital None None None None None None None Jeffrey L. Anderson Intermountain Medical Center None None None None None AstraZeneca * None Gary J. Balady Boston Medical Center None None None None None None None Eric R. Bates University of Michigan None None None None None AstraZeneca * ; Daiichi Sankyo * ; Eli Lilly * ; Merck * ; Sanofi Aventis * None Vera Bittner University of Alabama at Birmingham Clinical site PI for multicenter trials funded by: Roche/Genentech † ; Gilead; GSK † ; NIH/Abbott † ; NIH/Yale † None None None None Roche/Genentech * ; Amarin * ; Pfizer * None Ann F. Bolger University of California, San Francisco None None None None None None None Victor A. Ferrari University of Pennsylvania None None None None None Board of Trustees, Society for Cardiovascular Magnetic Resonance (no monetary value) * ; Editorial Board, Journal of Cardiovascular Magnetic Resonance (no monetary value) * None Stephan Fihn Department of Veterans Affairs and University of Washington None None None None None None None Gregg Fonarow UCLA NHLBI † ; AHRQ † None None None None Novartis † ; Medtronic * None Federico Gentile Centro Medico diagnostic, Naples-Italy None None None None None None None Larry B. Goldstein Duke University None None None None None None None Jonathan Halperin Mount Sinai Medical Center None None None None None Boehringer Ingelheim † ; Astellas Pharma, US * ; Bristol-Myers Squibb * ; Daiichi Sankyo * ; Johnson &amp;amp;amp;amp; Johnson * ; Pfizer, Inc * ; Sanofi-Aventis * None Courtney Jordan University of Minnesota None None None None None None None Noel Bairey Merz Cedars-Sinai Medical Center Gilead † NHLBI † Mayo Foundation * ; SCS Healthcare † ; Practice Point Communications * ; Inst for Professional Education * ; Medical Education Speakers Network * ; Minneapolis Heart Institute * ; Catholic Healthcare West * ; Novant Health * ; HealthScience Media Inc * ; Huntsworth Health * ; WomenHeart Coalition * ; Los Robles Medical Center * ; Monterrey Community Hospital (honorarium, donated to ACC) * ; Los Angeles OB-GYN Society * ; Pri-Med * ; North American Menopause Society * None Medtronic † UCSF * ; Society for Women's Health Research * ; Interquest * ; Dannemiller * ; Navvis &amp;amp;amp;amp; Co * ; Springer SBM LLC * ; Duke * ; NHLBI * ; Italian National Institutes of Health * ; Gilead * None L. Kristin Newby Duke University None None None None None None None Patrick O'Gara Brigham &amp;amp;amp;amp; Women's Hospital None None None None None Lantheus Medical Imaging * None Thomas W. Rooke Mayo Clinic None None None None None Merck–Adjudication (Event) Committee * None Vincent Sorrell University of Arizona None None Lantheus Medical Imaging † None None None None

PY - 2011/11/29

Y1 - 2011/11/29

KW - AHA Scientific Statements

KW - coronary disease

KW - risk factors

KW - secondary prevention

KW - vascular disease

UR - http://www.scopus.com/inward/record.url?scp=81855224663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81855224663&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2011.10.824

DO - 10.1016/j.jacc.2011.10.824

M3 - Article

C2 - 22055990

AN - SCOPUS:81855224663

SN - 0735-1097

VL - 58

SP - 2432

EP - 2446

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 23

ER -

AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this